Kim Seo-Young, Kim Joo Young, Kim Seol-Hee, Bae Hyun Jin, Yi Hwaseon, Yoon Sang Hong, Koo Bon Sung, Kwon Moosik, Cho Jae Youl, Lee Choong-Eun, Hong Sungyoul
Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
FEBS Lett. 2007 Mar 6;581(5):865-71. doi: 10.1016/j.febslet.2007.01.059. Epub 2007 Feb 2.
The effect of surfactin on the proliferation of LoVo cells, a human colon carcinoma cell line, was examined. Surfactin strongly blocked the proliferation of LoVo cells by inducing pro-apoptotic activity and arresting the cell cycle, according to several lines of evidence on DNA fragmentation, Annexin V staining, and altered levels of poly (ADP-ribose) polymerase, caspase-3, p21(WAF1/Cip1), p53, CDK2 and cyclin E. The anti-proliferative activity of surfactin was mediated by inhibiting extracellular-related protein kinase and phosphoinositide 3-kinase/Akt activation, as assessed by phosphorylation levels. Therefore, our data suggest that surfactin may have anti-cancer properties as a result of its ability to downregulate the cell cycle and suppress its survival.
研究了表面活性素对人结肠癌细胞系LoVo细胞增殖的影响。根据关于DNA片段化、膜联蛋白V染色以及聚(ADP-核糖)聚合酶、半胱天冬酶-3、p21(WAF1/Cip1)、p53、细胞周期蛋白依赖性激酶2(CDK2)和细胞周期蛋白E水平变化的多项证据,表面活性素通过诱导促凋亡活性和阻滞细胞周期,强烈地抑制了LoVo细胞的增殖。通过磷酸化水平评估发现,表面活性素的抗增殖活性是通过抑制细胞外相关蛋白激酶和磷酸肌醇3激酶/蛋白激酶B(PI3K/Akt)激活来介导的。因此,我们的数据表明,表面活性素可能因其下调细胞周期和抑制细胞存活的能力而具有抗癌特性。